🌱 KidneyEnergy.com

← brief for 2026-10-13 · Slowing decline

Long-term metabolic regulation in the era of GLP-1 receptor agonists: An integrative review of Ayurvedic and biomedical perspectives.

Article C Peer reviewed Observational

Key takeaways

This review looks at how GLP-1 drugs, like semaglutide, help with weight and kidney health. It also looks at how Ayurvedic medicine views these same issues. It shows a link between these treatments and better health, but it is not proof of cause. It helps doctors see the big picture of long-term care.

Who did this work

Naikare T · Waghulkar M

Source

Article · PubMed, the drug frontier · 2026 Oct 12
https://pubmed.ncbi.nlm.nih.gov/42868875/